Literature DB >> 18547114

Alpha-glucosidase inhibitor from Kothala-himbutu (Salacia reticulata WIGHT).

Sei Ozaki1, Hiromi Oe, Shinichi Kitamura.   

Abstract

A polyhydroxylated cyclic 13-membered sulfoxide (1) was isolated from an aqueous extract of Kothala-himbutu ( Salacia reticulata WIGHT). The structure of compound 1 was elucidated by 1D and 2D NMR and APCI-MS methods. The alpha-glucosidase inhibitory activity of compound 1 (IC 50: maltase, 0.227 microM; sucrase, 0.186 microM; isomaltase, 0.099 microM) was much greater than the inhibitory activity of salacinol and kotalanol, which were previously isolated from Kothala-himbutu.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547114     DOI: 10.1021/np070604h

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Quantitative analysis of neosalacinol and neokotalanol, another two potent α-glucosidase inhibitors from Salacia species, by LC-MS with ion pair chromatography.

Authors:  Osamu Muraoka; Toshio Morikawa; Sohachiro Miyake; Junji Akaki; Kiyofumi Ninomiya; Yutana Pongpiriyadacha; Masayuki Yoshikawa
Journal:  J Nat Med       Date:  2010-10-28       Impact factor: 2.343

2.  Modulation of starch digestion for slow glucose release through "toggling" of activities of mucosal α-glucosidases.

Authors:  Byung-Hoo Lee; Razieh Eskandari; Kyra Jones; Kongara Ravinder Reddy; Roberto Quezada-Calvillo; Buford L Nichols; David R Rose; Bruce R Hamaker; B Mario Pinto
Journal:  J Biol Chem       Date:  2012-07-31       Impact factor: 5.157

3.  Salacia Extract Improves Postprandial Glucose and Insulin Response: A Randomized Double-Blind, Placebo Controlled, Crossover Study in Healthy Volunteers.

Authors:  Shankaranarayanan Jeykodi; Jayant Deshpande; Vijaya Juturu
Journal:  J Diabetes Res       Date:  2016-10-10       Impact factor: 4.011

4.  Preventive Effects of Salacia reticulata on Obesity and Metabolic Disorders in TSOD Mice.

Authors:  Tomoko Akase; Tsutomu Shimada; Yukiko Harasawa; Tomohide Akase; Yukinobu Ikeya; Eiichi Nagai; Seiichi Iizuka; Gojiro Nakagami; Shinji Iizaka; Hiromi Sanada; Masaki Aburada
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-23       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.